Understand the source comparison
Best Peptides for Cognitive Decline: Research Comparison
Selecting the appropriate peptide for cognitive decline research requires matching mechanism to research question. The table below compares primary mechanisms, administration routes, and key research applications for leading cognitive peptides. | Peptide | Pri
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Selecting the appropriate peptide for cognitive decline research requires matching mechanism to research question. The table below compares primary mechanisms, administration routes, and key research applications for leading cognitive peptides.
- | Peptide | Primary Mechanism | Administration Route | Typical Research Dose | Key Application | Research Evidence Level | Professional Assessment ||—|—|—|—|—|—|| Cerebrolysin | BDNF/NGF mimetic, TrkB activation | IV or IM injection | 10–30 mL daily | Vascular dementia, stroke recovery | 16+ RCTs, 2,400+ patients | Gold standard for neurotrophic research. Extensive human data || Dihexa | HGF potentiation, synaptogenesis | Oral or subcutaneous | 2–5 mg/kg | Alzheimer's models, synaptic plasticity | Preclinical rodent models | Highest potency for synaptogenesis. Limited human data || P21 | CREB pathway activation | Intranasal | 1–2 mg/kg | Memory consolidation, age-related decline | Rodent behavioral studies | Best selectivity for memory encoding. Intranasal delivery advantage || Semax Amidate | Melanocortin receptor, enkephalinase inhibition | Intranasal | 300–600 mcg | Stroke, executive function, ADHD models | Russian clinical trials, 500+ patients | Fastest CNS penetration. Proven str